FDA limits Janssen COVID-19 vaccine and announces tentative vaccines discussion. NIH updates Evusheld second dose guidance.
COVID-19 Summary of Evidence report updated, FDA approves first COVID-19 treatment for young children and authorizes breath samples diagnostic test
Sotrovimab distribution paused nationwide, how to locate Evusheld therapy and answers to your patients important questions
Answer your patient’s important questions and locate Evusheld therapy; OPTN Policy 1.4.F expires soon; and FDA authorizes second booster
Emergency policy had been approved for a 90-day period.
Resources for members to share with patients. New COVID-19 data element added to Center STAR files.